Anticholium Injection
Product Images NDC 81284-831

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Anticholium (NDC 81284-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Provepharm Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ampule (Anticholium Ampule)

Label for ANTICHOLIUM 0.4 mg/mL (2 mg/5 mL) solution for injection, indicated for intravenous use. The active ingredient is physostigmine salicylate. The label shows the manufacturer as Dr. Franz Köhler Chemie GmbH, located in Bensheim, Germany, with lot and expiration date fields.*

FDA Label Image

Carton (Anticholium Carton)

Packaging label for ANTICHOLIUM 0.4 mg/mL injection, a solution for intravenous use. The label specifies 5 vials of 5 mL each, containing physostigmine salicylate as the active ingredient. The manufacturer is Dr. Franz Köhler Chemie GmbH, located in Bensheim, Germany. Additional formulation details and storage instructions are included.*

FDA Label Image

Us Product Label (Dhcp 1)

Label for Physostigmine Salicylate Injection, 1 mg/mL in a 2 mL single dose ampule. The product is indicated for intramuscular or intravenous use and distributed by Akorn, Gurnee, IL. This label includes the NDC number 17478-510-02 and spaces for lot and expiration information.*

FDA Label Image

Import Product Label (Dhcp 2)

Label for ANTICHOLIUM 0.4 mg/mL (2 mg/5 mL) solution for injection, containing the active substance physostigmine salicylate for intravenous use. Manufactured by Dr. Franz Köhler Chemie GmbH, Bensheim, Germany. The label indicates a 5 mL vial size and includes lot and expiration date fields, as well as a version code V01/05.23.*

FDA Label Image

List Of Adverse Reactions (Dhcp 3)

A data table listing various system organ classes alongside associated adverse reaction frequencies labeled 'Unknown.' It includes categories such as immune system disorders, endocrine disorders, heart diseases, vascular diseases, respiratory disorders, gastrointestinal disorders, and skin and subcutaneous tissue disorders, with corresponding reactions such as hypersensitivity, hypersalivation, heart rhythm changes, hypotension, bronchospasms, nausea, vomiting, and sweating.*

FDA Label Image

List Of Adverse Reactions (Dhcp 4)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.